Australia markets closed

Merck KGaA (0O14.IL)

IOB - IOB Delayed price. Currency in EUR
Add to watchlist
156.45+1.35 (+0.87%)
At close: 05:35PM BST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
20,870,000
20,993,000
22,232,000
19,687,000
17,534,000
Cost of revenue
8,719,000
8,600,000
8,527,000
7,351,000
6,835,000
Gross profit
12,151,000
12,393,000
13,705,000
12,336,000
10,699,000
Operating expenses
Research development
2,475,000
2,445,000
2,521,000
2,426,000
2,288,000
Selling general and administrative
5,255,000
5,306,000
5,403,000
4,941,000
4,760,000
Total operating expenses
8,867,000
8,816,000
8,953,000
8,127,000
7,889,000
Operating income or loss
3,284,000
3,577,000
4,752,000
4,209,000
2,810,000
Interest expense
293,000
321,000
235,000
272,000
387,000
Income before tax
3,262,000
3,484,000
4,287,000
3,924,000
2,630,000
Income tax expense
629,000
650,000
948,000
859,000
637,000
Income from continuing operations
2,633,000
2,834,000
3,339,000
3,065,000
1,994,000
Net income
2,626,000
2,824,000
3,326,000
3,055,000
1,987,000
Net income available to common shareholders
2,626,000
2,824,000
3,326,000
3,055,000
1,987,000
Basic EPS
6.66
6.49
7.65
7.03
4.57
Diluted EPS
6.66
6.49
7.65
7.03
4.57
Basic average shares
434,438
434,778
434,778
434,778
434,778
Diluted average shares
434,438
434,778
434,778
434,778
434,778